Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
BMJ Open Qual ; 13(1)2024 02 13.
Article in English | MEDLINE | ID: mdl-38351031

ABSTRACT

INTRODUCTION: Quality improvement collaboratives (QICs) are a common approach to facilitate practice change and improve care delivery. Attention to QIC implementation processes and outcomes can inform best practices for designing and delivering collaborative content. In partnership with a clinically integrated network, we evaluated implementation outcomes for a virtual QIC with independent primary care practices delivered during COVID-19. METHODS: We conducted a longitudinal case study evaluation of a virtual QIC in which practices participated in bimonthly online meetings and monthly tailored QI coaching sessions from July 2020 to June 2021. Implementation outcomes included: (1) level of engagement (meeting attendance and poll questions), (2) QI capacity (assessments completed by QI coaches), (3) use of QI tools (plan-do-check-act (PDCA) cycles started and completed) and (4) participant perceptions of acceptability (interviews and surveys). RESULTS: Seven clinics from five primary care practices participated in the virtual QIC. Of the seven sites, five were community health centres, three were in rural counties and clinic size ranged from 1 to 7 physicians. For engagement, all practices had at least one member attend all online QIC meetings and most (9/11 (82%)) poll respondents reported meeting with their QI coach at least once per month. For QI capacity, practice-level scores showed improvements in foundational, intermediate and advanced QI work. For QI tools used, 26 PDCA cycles were initiated with 9 completed. Most (10/11 (91%)) survey respondents were satisfied with their virtual QIC experience. Twelve interviews revealed additional themes such as challenges in obtaining real-time data and working with multiple electronic medical record systems. DISCUSSION: A virtual QIC conducted with independent primary care practices during COVID-19 resulted in high participation and satisfaction. QI capacity and use of QI tools increased over 1 year. These implementation outcomes suggest that virtual QICs may be an attractive alternative to engage independent practices in QI work.


Subject(s)
COVID-19 , Quality Improvement , Humans , Cooperative Behavior , Ambulatory Care Facilities , Primary Health Care/methods
2.
Eur Urol Focus ; 8(4): 1042-1052, 2022 07.
Article in English | MEDLINE | ID: mdl-34563480

ABSTRACT

CONTEXT: No meta-analysis has comprehensively addressed both benefits and harms, or the certainty of evidence of the implantable continence devices used in men to treat postprostatectomy urinary incontinence (PPI). OBJECTIVE: To evaluate the benefits and harms of surgical treatments for patients suffering from PPI and assess the certainty of evidence. The primary benefit was cure (one or fewer pad per day), and the primary harm was reoperations defined by surgical procedures following implantation. EVIDENCE ACQUISITION: We perform a search of Medline, PubMed, Embase, Cochrane Library, and gray literature. We included observational studies addressing PPI surgical interventions if they involved cohorts of ≥50 participants. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach provided the framework for certainty of evidence assessment informed by value and preference judgments provided by patients, and an advocacy group member (Canadian Cancer Society). EVIDENCE SYNTHESIS: Of 85 observational studies involving 13 100 patients, three addressed bulking agents, 35 male synthetic slings, ten adjustable continence therapies (ACTs), and 37 artificial urinary sphincters (AUSs). Cure was 26.1% (95% confidence interval [CI]: 10.6-51.4, I2 = 92.8%, very-low-quality evidence) for bulking agents, 58.6% (95% CI: 51.3-65.5, I2 = 89.1%, low-quality evidence) for slings, 63.2% (95% CI: 57.6-68.5, I2 = 22.5%, very-low-quality evidence) for ACT, and 74.0% (95% CI:61.2-83.7, I2 = 92.1%, very-low-quality evidence) for AUS. Estimated rates of reoperation were 5.8% (95% CI: 1.9-11.6, I2 = 94.1%, moderate-quality evidence) for slings, 23.8% (95% CI: 5.9-61.0, I2 = 95.5%, low-quality evidence) for ACT, and 22.2% (95% CI: 15.2-31.3, I2 = 92.3%, high-quality evidence) for AUS. CONCLUSIONS: Available evidence regarding the benefits of surgical interventions for PPI remains mainly uncertain while suggesting important harms. These results should guide consent procedures for PPI surgery in the context of shared decision-making, with disclosure of the uncertainty of evidence. PATIENT SUMMARY: Despite being used worldwide, available evidence regarding the benefits of surgeries to treat postprostatectomy urinary incontinence remains mainly uncertain while suggesting important harms. This highlights the need for a more rigorous evaluation process for commercially available surgical devices.


Subject(s)
Suburethral Slings , Urinary Incontinence , Urinary Sphincter, Artificial , Canada , Humans , Male , Prostatectomy/adverse effects , Prostatectomy/methods , Urinary Incontinence/etiology , Urinary Incontinence/surgery
3.
Can J Anaesth ; 67(9): 1249-1259, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32592108

ABSTRACT

PURPOSE: We performed a systematic review of the literature to identify the ideal blood pressure (BP) target in neurologically deceased organ donors to optimize outcomes of recipient organ function and survival, and organs transplanted per donor. SOURCE: We searched MEDLINE and EMBASE from inception to December 2018 for studies that evaluated BP targets in neurologically deceased organ donors. A two-step review process with three independent reviewers was employed. We assessed the risk of bias and applied Grading of Recommendations Assessment, Development, and Evaluation methodology to evaluate the certainty of the evidence by outcome. PRINCIPAL FINDINGS: Twelve cohort studies were included in our final analysis. Seven studies showed that hypotension was associated with worse post-transplant graft function or survival, while three studies found no association between hypotension and post-transplant graft function or survival. Two other studies showed no association between hypotension and organs transplanted per donor. Overall, six of the identified studies had serious risk of bias. CONCLUSION: A systolic BP less 90 mmHg may be associated with graft dysfunction in kidney recipients, but this is based on very low certainty in evidence. Although an ideal and universal BP target in neurologically deceased organ donors is not clearly identifiable in the literature, this could reflect the complexity of donor hemodynamics and the need for individualized targets for different organs. Further prospective research is required to address these questions.


RéSUMé: OBJECTIF: Nous avons réalisé une revue systématique de la littérature afin d'identifier la tension artérielle (TA) idéale chez les donneurs d'organes après un décès neurologique en vue d'optimiser les devenirs en matière de fonctionnement d'organes et de survie, ainsi que le nombre d'organes transplantés par donneur. SOURCE: Nous avons effectué des recherches dans les bases de données MEDLINE et EMBASE de leur création jusqu'en décembre 2018 afin d'en extraire les études évaluant les cibles de TA chez les donneurs d'organes après un décès neurologique. Nous avons utilisé un processus de révision en deux étapes comprenant trois réviseurs indépendants. Nous avons évalué le risque de biais et appliqué la méthodologie GRADE (Grading of Recommendations Assessment, Development and Evaluation) afin d'évaluer la certitude des données probantes par résultat. CONSTATATIONS PRINCIPALES: Douze études de cohorte ont été incluses dans notre analyse finale. Sept études ont révélé que l'hypotension était associée à un fonctionnement moins bon ou une survie moins bonne du greffon après la greffe, alors que trois études n'ont trouvé aucune association entre l'hypotension et le fonctionnement ou la survie du greffon post-transplantation. Deux autres études n'ont montré aucune association entre l'hypotension et le nombre d'organes transplantés par donneur. Dans l'ensemble, six des études identifiées comportaient un important risque de biais. CONCLUSION: Une TA systolique de moins de 90 mmHg pourrait être associée à un dysfonctionnement du greffon chez les récipiendaires de reins, mais ce risque se fonde sur une certitude très faible des données probantes. Bien qu'une cible de TA idéale et universelle chez les donneurs d'organes après un décès neurologique ne soit pas clairement identifiée dans la littérature, cela pourrait refléter la complexité de l'hémodynamie des donneurs et le besoin de cibles individualisées selon les différents organes. Des recherches prospectives supplémentaires sont nécessaires pour explorer ces questions.


Subject(s)
Transplant Recipients , Blood Pressure , Graft Survival , Humans , Tissue Donors , Tissue and Organ Procurement
4.
Small GTPases ; 10(3): 196-209, 2019 05.
Article in English | MEDLINE | ID: mdl-28430047

ABSTRACT

Arf GTPase-activating proteins (Arf GAPs) were first identified as regulators of the small GTP-binding proteins ADP-ribosylation factors (Arfs). The Arf GAPs are a large family of proteins in metazoans, outnumbering the Arfs that they regulate. The members of the Arf GAP family have complex domain structures and some have been implicated in particular cellular functions, such as cell migration, or with particular pathologies, such as tumor invasion and metastasis. The specific effects of Arfs sometimes depend on the Arf GAP involved in their regulation. These observations have led to speculation that the Arf GAPs themselves may affect cellular activities in capacities beyond the regulation of Arfs. Recently, 2 Arf GAPs, ASAP1 and AGAP1, have been found to bind directly to and influence the activity of myosins and kinesins, motor proteins associated with filamentous actin and microtubules, respectively. The Arf GAP-motor protein interaction is critical for cellular behaviors involving the actin cytoskeleton and microtubules, such as cell migration and other cell movements. Arfs, then, may function with molecular motors through Arf GAPs to regulate microtubule and actin remodeling.


Subject(s)
Actin Cytoskeleton/metabolism , Adaptor Proteins, Signal Transducing/metabolism , Cell Movement/physiology , GTPase-Activating Proteins/metabolism , Kinesins/metabolism , Myosins/metabolism , Actin Cytoskeleton/genetics , Adaptor Proteins, Signal Transducing/genetics , Animals , GTPase-Activating Proteins/genetics , Humans , Kinesins/genetics , Microtubules/genetics , Microtubules/metabolism , Myosins/genetics , Protein Domains
5.
Am J Perinatol ; 31(6): 455-62, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23884718

ABSTRACT

OBJECTIVE: To evaluate the effect of mode and amount of fluid hydration during labor. STUDY DESIGN: The authors conducted a randomized controlled trial of uncomplicated nulliparous women in spontaneous labor at 36 weeks or more gestational age. Women were randomized to receive lactated Ringer solution with 5% dextrose at (1) 125 mL/h intravenously with limited oral intake, (2) 250 mL/h intravenously with limited oral intake, or (3) 25 mL/h intravenously with ad libitum oral intake of clear liquids. Results were analyzed by intent-to-treat analysis. RESULTS: A total of 311 out of 324 women were available for analysis. Groups 1 (n = 105), 2 (n = 105), and 3 (n = 101) above did not differ significantly for mean labor duration (11.6 ± 5.9, 11.4 ± 5.5, and 11.5 ± 5.9 hours, respectively; p = 0.998), proportion of women in labor > 12 hours (all groups 41%; p = 0.998), proportion receiving oxytocin augmentation (59, 60, and 57%, respectively; p = 0.923), or proportion delivered by cesarean (22, 17, and 17%, respectively; p = 0.309). Indications for cesarean were similar between groups. No cases of pulmonary edema, maternal aspiration, or perinatal mortality occurred. CONCLUSION: Although apparently safe, neither increased intravenous hydration nor oral hydration during labor improves labor performance.


Subject(s)
Fluid Therapy/methods , Labor, Obstetric , Administration, Intravenous , Administration, Oral , Adolescent , Adult , Candy , Cesarean Section , Female , Glucose/administration & dosage , Humans , Ice , Isotonic Solutions/administration & dosage , Labor, Obstetric/physiology , Oxytocics/administration & dosage , Oxytocin/administration & dosage , Parity , Pregnancy , Ringer's Solution , Time Factors , Water/administration & dosage , Young Adult
6.
J Food Sci ; 77(6): C719-26, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22591108

ABSTRACT

UNLABELLED: New Zealand is a leader in the global dairy industry. Milk powder is the principal export product, but there is also a prominent cheese manufacturing industry, catering more for the domestic market. The Selected Ion Flow Tube-Mass Spectrometric (SIFT-MS) technique was used to compare 4 New Zealand cheeses marketed as "parmesan" with 4 Italian Parmigiano Reggiano and Grana Padano cheeses. The cheese headspace was analyzed in real time without any sample preconcentration. Total of 38 volatile compounds in the cheese headspace were monitored with headspace concentrations varying between single digit parts per billion (ppb) to tens of parts per million (ppm). When the results were subjected to multivariate statistical analysis, a clear discrimination was found between the New Zealand "parmesan" and Italian cheeses based solely on the measured concentrations of these volatile compounds. If the volatile compounds used in the analyses were restricted to known odor-active compounds in Parmigiano Reggiano cheese, the ability to discriminate between the cheeses was maintained. The analyses also showed that it was possible to clearly differentiate between the different processing plants in individual countries. Important discriminatory volatiles in the samples tested were butanoic acid and phenylacetaldehyde for discriminating between Italian cheeses and ethyl butyrate, acetaldehyde and methylbutanals between New Zealand cheeses. We conclude that the New Zealand "parmesans" do not provide a good representation of the aroma of Italian "parmesans." PRACTICAL APPLICATION: SIFT-MS has been shown to clearly differentiate both country of origin and the manufacturer of "parmesan" cheeses made in Italy and New Zealand based on differences in volatile organic compounds. Thus this method will have benefit for use in the quality control of "parmesan" and other cheese varieties.


Subject(s)
Cheese/analysis , Diet/ethnology , Food Inspection/methods , Volatile Organic Compounds/analysis , Acetaldehyde/analogs & derivatives , Acetaldehyde/analysis , Aldehydes/analysis , Butyrates/analysis , Butyric Acid/analysis , Italy , Mass Spectrometry , New Zealand , Odorants , Principal Component Analysis , Quality Control , Reproducibility of Results
7.
J Am Soc Nephrol ; 13(5): 1152-61, 2002 May.
Article in English | MEDLINE | ID: mdl-11961002

ABSTRACT

This study examined the events associated with the reversible disruption of the structural and functional integrity of the zonula occludens (ZA) induced by ATP depletion of renal tubular cells. It shows that loss of the ZA after ATP depletion is associated with the withdrawal of E-cadherin, alpha-catenin, and beta-catenin, probably as intact cadherin-catenin complexes from the basolateral membrane of tubular cells. The relative amounts of all three proteins increased in the Triton X-100-insoluble fraction of cell lysates and decreased in the Triton X-100-soluble pool. These changes were reversed with repletion of cell ATP. It is additionally shown that ATP depletion induces nuclear translocation of beta-catenin and T cell factor (TCF)/lymphoid enhancer factor-1 (LEF-1), a transcriptional factor with which beta-catenin associates. The redistribution of the ZA proteins as intact E-cadherin-catenin complexes from the plasma membrane facilitates the rapid recovery of the ZA after sublethal ischemic injury. The translocation of beta-catenin and TCF/LEF-1 to the nucleus indicates that ATP depletion may activate the wnt/wingless signal transduction pathway. Thus, entirely novel evidence is provided that both of the known roles of beta-catenin, as a structural part of the ZA and as a component of the wnt/wingless pathway, play a role after sublethal ischemic injury to tubular cells. It is also speculated that the nuclear translocation of beta-catenin and TCF/LEF-1 modulates gene expression after ischemic injury and may contribute to events necessary for renal regeneration and repair after ischemic injury.


Subject(s)
Cell Nucleus/metabolism , Cytoskeletal Proteins/metabolism , DNA-Binding Proteins/metabolism , Kidney Tubules/metabolism , Trans-Activators/metabolism , Transcription Factors/metabolism , Adenosine Triphosphate/pharmacology , Animals , Cells, Cultured , Immunoblotting , Immunohistochemistry , Intracellular Membranes/metabolism , Kidney Tubules/cytology , Lymphoid Enhancer-Binding Factor 1 , Opossums , Signal Transduction , beta Catenin
SELECTION OF CITATIONS
SEARCH DETAIL
...